Horizon Space Acquisition II Corp. Right

SL BIO Ltd. completed its business combination with Horizon Space Acquisition II Corp., creating SL Science Holding Limited, which began trading on Nasdaq under ticker 'SLBT' on June 15, 2026. The transaction valued SL Bio at approximately $5.568 billion and raised $7.8 million in PIPE financing. The company plans to advance its proprietary Gamma...

Horizon Space Acquisition II Corp. (HSPT) clarified its redemption process for shareholders ahead of two upcoming meetings: a Business Combination Meeting on February 12, 2026 to vote on merging with SL BIO Ltd., and an Extension Meeting on February 13, 2026 to vote on extending the deadline for completing the initial business combination. Shareh...

Taiwan-based biotechnology firm SL Bio Ltd. has filed a Form F-4 to merge with Horizon Space Acquisition II Corp. (NASDAQ:HSPT), taking the company public via SPAC at an implied equity valuation of $5.7 billion. The combined entity will operate as SL Science Holding Limited under ticker SLBT, with the public listing expected in early 2026. SL Bio...